From April 1, 2024 to April 17, 2024, the company has repurchased 500 shares, representing 0.000034% for CNY 0.007505 million. With this, the company has completed the repurchase of 7,023,600 shares, representing 0.48% for CNY 99.99 million under the buyback announced on November 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.75 CNY | +3.97% | +5.74% | +14.18% |
May. 02 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
Apr. 29 | Zhejiang Huahai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.18% | 3.41B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023.